Buy & Sell Innovative Industrial Properties Inc (IIPR) – Innovative Industrial Properties Inc Price Today
Aura AI Summary
Key Stats
- $1.57BMarket Cap
- Real EstateSector
- -12.95%3M Drawdown
- $1.95BEnterprise Value
- 13.96%Dividend Yield
- 33% Buy | 67% SellTrading Activity
- 76 daysTypical Hold Time
Innovative Industrial Properties Inc (IIPR) is currently valued at a market capitalization of $1.57B, with an enterprise value of $1.95B. Over the past 52 weeks, Innovative Industrial Properties Inc has traded between a low of $44.58 and a high of $60.32, highlighting its annual price range. Over the past three months, Innovative Industrial Properties Inc has recorded a drawdown of -12.95%, reflecting recent price volatility. Innovative Industrial Properties Inc offers a dividend yield of 13.96%, with the most recent dividend of $1.90 paid on 31 Mar 26. On average, investors hold Innovative Industrial Properties Inc for approximately 76 days, indicating typical investor behavior on the platform.
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Most Recent News
BC launches Outdoor Sector Coalition to boost economy, health, and conservation of its outdoors.
A coalition of over 2,000 organizations in British Columbia has formed to support the province's outdoor sector, which is a $17 billion industry employing 80,000 people. The coalition aims to enhance health benefits, support outdoor businesses, and p...
Nvidia's Q1 2027 earnings face high expectations amid strong past beats but mixed stock reactions.
Nvidia is set to report its Q1 2027 earnings with Wall Street expecting $78.8 billion in revenue and $1.77 EPS, marking record growth. Historically, Nvidia has consistently beaten revenue and EPS estimates, but recent earnings have shown that the sto...
ESR1-mutated metastatic breast cancer market to grow 9.6% CAGR with new oral SERDs and targeted therapies.
The ESR1-mutated metastatic breast cancer market is projected to grow rapidly at a 9.6% CAGR from 2026 to 2036, driven by rising cases of endocrine-resistant HR-positive/HER2-negative breast cancer and advances in precision oncology. Novel therapies ...
